What Can we Learn About the Aetiology of Hodgkin’s Disease from Family Studies?

  • Paul H. Levine
  • Albert Lin
  • Margaret A. Tucker
Part of the NATO ASI Series book series (NSSA, volume 280)


Family studies have given us an important tool in understanding the aetiology of cancer. There are many examples, such as malignant melanoma and nasopharyngeal carcinoma, where the interaction of genetic and environmental factors is important in producing the observed pattern of disease. In the case of malignant melanoma, for example, a subset of the population has been identified with hereditary predisposition to melanoma associated with dysplastic nevi (Clark et al., 1978; Reimer et al., 1978). The pattern of inheritance appears to be dominant with approximately 90% penetrance. Environment plays a role in this genetically determined malignancy since the risk of melanoma in people with dysplastic nevi is related to the number of sunburns. Education and counselling of susceptible family members regarding sun exposure apparently changes their exposure patterns. Within several years of less sun exposure, the number of new melanomas and dysplastic nevi decrease in the individuals following skin care guidelines (Tucker, 1986). In nasopharyngeal carcinoma, the genetic aspects and the environmental aspects remain speculative. HLA loci have been linked to a putative disease-susceptibility gene in some specific multiple case families. The putative environmental factors include Epstein-Barr virus (EBV), exposure to nitrosamines, cigarette smoke, and other agents (Hildesheim and Levine, 1993). Nasopharyngeal carcinoma appears to be in the middle of a spectrum ranging from ataxia telangiectasia and xeroderma pigmentosum, where genetics appear to be the most important contributing factor, to adult T-cell leukaemia/lymphoma where the exposure to the oncogenic virus, HTLV-I, at an early age is clearly far more important than genetic susceptibility (Murphy et al., 1989).


Nasopharyngeal Carcinoma Xeroderma Pigmentosum Ataxia Telangiectasia Nodular Sclerosis Dysplastic Nevus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB, MacMahon EME, Medina R, Cardona V, Grufferman S, Olshan A, Levin A, Petersen EA, Blattner W, Levine PH (1993) Epstein-Barr virus and childhood Hodgkin’s disease in Honduras and the United States. Blood 81:462PubMedGoogle Scholar
  2. Bignon Y-J, Bernard D, Curé H, Fonck Y, Pauchard J, Travade P, Legros M, Dastugue B, Piagne R (1990) Detection of Epstein-Barr viral genomes in lymph nodes of Hodgkin’s disease patients. Mol Carcinogenesis 3:9CrossRefGoogle Scholar
  3. Chakravarti A, Halloran SL, Bale SJ, Tucker MA (1986) Etiological heterogeneity in Hodgkin’s disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance. Genetic Epidemiol 3:407CrossRefGoogle Scholar
  4. Clark WH Jr, Reimer R, Greene MH, Ainsworth A, Mastrangelo M (1978) Origin of familial malignant melanoma from heritable melanocytic lesions. Arch Derm 114:732PubMedCrossRefGoogle Scholar
  5. Cole P, MacMahon B, Aisenberg A (1968) Mortality from Hodgkin’s disease in the U.S. Lancet ii: 1371CrossRefGoogle Scholar
  6. Correa P, O’Conor GT (1971) Epidemiologic patterns of Hodgkin’s disease. Int J Cancer 8:192PubMedCrossRefGoogle Scholar
  7. Dubey DP, Alper CA, Mirza NM, Awdeh Z, Yunis EJ (1994) Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity. J Exp Med 179:1193PubMedCrossRefGoogle Scholar
  8. Greene MH, McKeen EA, Li FP, Blattner WA, Fraumeni JF Jr (1979) HLA antigens in familial Hodgkin’s disease. Int J Cancer 23:777PubMedCrossRefGoogle Scholar
  9. Grufferman S, Cole P, Smith PG, Lukes RJ (1977) Hodgkin’s disease in siblings. N Engl J Med 296:248PubMedCrossRefGoogle Scholar
  10. Grufferman S (1977) Clustering and aggregation of exposures in Hodgkin’s disease. Cancer 39:1829PubMedCrossRefGoogle Scholar
  11. Grufferman S. (1982) Hodgkin’s disease. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni Jr, JF, eds (Philadelphia: WB Saunders, Co.) p739Google Scholar
  12. Gutensohn NM (1982) Social class and age at diagnosis of Hodgkin’s disease: new epidemiologic evidence for the “two-disease hypothesis”. Cancer Treat Rep 66:689PubMedGoogle Scholar
  13. Hildesheim A, Levine PH (1993) Etiology of nasopharyngeal carcinoma: a review. Epidemiol Reviews 15:466Google Scholar
  14. Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH, Cartwright RA, Onions DE (1991) Detection of Epstein-Barr virus genomes in Hodgkin’s disease: relation to age. J Clin Pathol 44:844PubMedCrossRefGoogle Scholar
  15. Lin A, Whitehouse J, Shaw G, Tucker A (1993) Familial aggregation of Hodgkin’s disease in a cohort of 48 families. Proc Annu Meet Am Soc Clin Oncol 12:184Google Scholar
  16. Lin A, Kingma D, Lennette E, Jaffe E, Ambinder R, Levine P, Tucker M (1994) Epstein-Barr virus is not associated with familial Hodgkin’s disease. Proc Annu Meet Am Soc Clin Oncol 13:5Google Scholar
  17. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taypor CR, Hamilton AS, Deapen DM, Rappaport EB (1995) Concordance for Hodgkin’s disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413PubMedCrossRefGoogle Scholar
  18. MacMahon B (1966) Epidemiological evidence on the nature of Hodgkin’s disease. Cancer Res 26:1189PubMedGoogle Scholar
  19. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43:250PubMedCrossRefGoogle Scholar
  20. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin’s disease. Lancet 337:320PubMedCrossRefGoogle Scholar
  21. Razis DV, Diamond HD, Carver LF (1959) Familial Hodgkin’s disease: its significance and implications. Ann Intern Med 51:933PubMedGoogle Scholar
  22. Reimer RR, Clark WH Jr, Greene MH, Ainsworth AM, Fraumeni JF Jr (1978) Precursor lesions in familial melanoma: a new genetic preneoplastic syndrome. JAMA 239:744PubMedCrossRefGoogle Scholar
  23. Shpilberg O, Modan M, Chetrit A, Modan B, Ramot B (1991) Familial aggregation of hematological malignancies among patients with Hodgkin’s disease. Second International Symposium on Hodgkin’s disease, October 3–5, 1991, Cologne, Germany, p29 (abstr)Google Scholar
  24. Tucker MA (1988) Individuals at high risk of melanoma. Pigment Cell 9:95Google Scholar
  25. Weiss LM, Movahed LA, Estmir RA (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502PubMedCrossRefGoogle Scholar
  26. Wright DH (1989) Pathology of Hodgkin’s disease: Anything New? In New Aspects in the Diagnosis and Treatment of Hodgkin’s disease. Recent Results in Cancer Research. Diehl V, Pfreundschuh M, Loeffler M, eds (Berlin, New York: Springer-Verlag) p2Google Scholar

Copyright information

© Plenum Press, New York 1995

Authors and Affiliations

  • Paul H. Levine
    • 1
  • Albert Lin
    • 2
  • Margaret A. Tucker
    • 2
  1. 1.Viral Epidemiology BranchNational Cancer InstituteBethesdaUSA
  2. 2.Genetic Epidemiology Branch, Epidemiology and Biostatistics ProgramNational Cancer InstituteBethesdaUSA

Personalised recommendations